CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Activity
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

97 hedge funds and large institutions have $192M invested in Concert Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+4
Holders Change %
+4.3%
% of All Funds
2.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
14
Increased
30
Reduced
36
Closed
10
Calls
$21K
Puts
$6K
Net Calls
+$15K
Net Calls Change
+$91K

Top Buyers

1
BI
BVF Inc
California
$37.6M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$4.79M
3
State Street
State Street
Massachusetts
$4.53M
4
AIC
AWM Investment Company
New York
$1.37M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$4.34M

Top Sellers

1
Millennium Management
Millennium Management
New York
$7.76M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$0
3
SFM
Sphera Funds Management
Israel
$0
4
BIM
Bogle Investment Management
Massachusetts
$281K
5
OAM
Oxford Asset Management
United Kingdom
$2.85M
Name Holding Trade Value Shares
Change 		Shares
Change %
AA
101
ALPS Advisors
Colorado
– -$491K -25,871 Closed
Connor, Clark & Lunn Investment Management (CC&L)
102
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$402K -21,200 Closed
Simplex Trading
103
Simplex Trading
Illinois
– -$47K -2,485 Closed
BJ
104
BlackRock Japan
Japan
– -$17K -893 Closed
TRCT
105
Tower Research Capital (TRC)
New York
– -$9K -456 Closed
Federated Hermes
106
Federated Hermes
Pennsylvania
– -$2K -112 Closed
JPMorgan Chase & Co
107
JPMorgan Chase & Co
New York
– -$1K -35 Closed
1 2 3 4
5